Leslie Farr
Family · Mechanicsville, VANPI 1770829079
Payments from drug & device makers
Across 80 payments — averaging $19.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$366
- Pfizer$301
- Sanofi$192
- Novartis$169
- Incyte Corporation$96
- Regeneron Healthcare Solutions, Inc.$92
- plus $377 from 10 others
What the payments were for
- Food & beverage$1,49394%
- Education$1006%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 26 | $366 |
| Pfizer | 15 | $301 |
| Sanofi | 7 | $192 |
| Novartis | 7 | $169 |
| Incyte Corporation | 4 | $96 |
| Regeneron Healthcare Solutions, Inc. | 3 | $92 |
| Arcutis Biotherapeutics, Inc. | 4 | $86 |
| AbbVie | 3 | $61 |
| Amgen | 2 | $52 |
| Almirall LLC | 2 | $50 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $37 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
How this compares
$1,593 in reported general payments places this provider in the 75th percentile of 4,332 family providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 163 | $9,823 |
| Fluorouracil | 98 | $7,157 |
| Ketoconazole | 173 | $4,487 |
| Metronidazole | 34 | $2,329 |
| Alclometasone Dipropionate | 28 | $1,773 |
| Doxycycline Hyclate | 86 | $1,632 |
| Triamcinolone Acetonide | 147 | $1,628 |
| Betamethasone Dipropionate | 13 | $950 |
| Minocycline Hcl | 21 | $860 |
| Ciclopirox | 27 | $592 |
| Mometasone Furoate | 12 | $299 |
| Nystatin | 14 | $282 |
| ValacyclovirValacyclovir Hcl | 23 | $223 |
| Cephalexin | 13 | $221 |
| Prednisone | 15 | $76 |
Paid to pharmacies, not to this prescriber.
Other family in Mechanicsville
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Norman JacobowitzManassas$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.